Axogen Valuation
| AXGN Stock | USD 31.76 0.76 2.45% |
At this time, the firm appears to be fairly valued. Axogen Inc shows a prevailing Real Value of $30.75 per share. The current price of the firm is $31.76. Our model approximates the value of Axogen Inc from analyzing the firm fundamentals such as Return On Equity of -0.0191, current valuation of 1.46 B, and Profit Margin of (0.01) % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Axogen's price fluctuation is not too volatile at this time. Calculation of the real value of Axogen Inc is based on 3 months time horizon. Increasing Axogen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Axogen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Axogen Stock. However, Axogen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 31.76 | Real 30.75 | Hype 31.56 | Naive 30.62 |
The intrinsic value of Axogen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Axogen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Axogen Inc helps investors to forecast how Axogen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Axogen more accurately as focusing exclusively on Axogen's fundamentals will not take into account other important factors: Axogen Total Value Analysis
Axogen Inc is presently forecasted to have valuation of 1.46 B with market capitalization of 1.43 B, debt of 68.69 M, and cash on hands of 58.03 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Axogen fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.46 B | 1.43 B | 68.69 M | 58.03 M |
Axogen Investor Information
About 92.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.05. Axogen Inc last dividend was issued on the 27th of January 2010. The entity had 105:100 split on the 11th of July 1994. Based on the analysis of Axogen's profitability, liquidity, and operating efficiency, Axogen Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Axogen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Axogen has an asset utilization ratio of 91.95 percent. This suggests that the Company is making $0.92 for each dollar of assets. An increasing asset utilization means that Axogen Inc is more efficient with each dollar of assets it utilizes for everyday operations.Axogen Ownership Allocation
Axogen holds a total of 46.12 Million outstanding shares. The majority of Axogen Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Axogen Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Axogen. Please pay attention to any change in the institutional holdings of Axogen Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Axogen Profitability Analysis
The company reported the previous year's revenue of 187.34 M. Net Loss for the year was (9.96 M) with profit before overhead, payroll, taxes, and interest of 160.52 M.About Axogen Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Axogen Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Axogen Inc based exclusively on its fundamental and basic technical indicators. By analyzing Axogen's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Axogen's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Axogen. We calculate exposure to Axogen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Axogen's related companies.AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 428 people.
Axogen Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 44.3 M | |
| Forward Price Earnings | 77.5194 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.